ConductScience.org, home

Paper37575813

Weight Loss or Liver Loss: A Case Report on Fulminant Hepatic Failure Secondary to Garcinia cambogia Supplementation.

Le D and 3 others. Cureus, 2023. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Weight Loss or Liver Loss: A Case Report on Fulminant Hepatic Failure Secondary to Garcinia cambogia Supplementation. Papers, record 37575813. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37575813

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Weight Loss or Liver Loss: A Case Report on Fulminant Hepatic Failure Secondary to Garcinia cambogia Supplementation.
PubMed
Journal
Cureus
PubMed
Year
2023
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.4
iCite
Revised in PubMed
2023-08-15
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Le DDanny
2Hydro BABrody A
3Jones CLChase L
4Beauchamp GAGillian A

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References7

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126626648Acute liver failure associated with Garcinia cambogia use.Ann Hepatol2016https://conductscience.org/library/papers/26626648PubMed
228018115Dangerous dietary supplements: Garcinia cambogia-associated hepatic failure requiring transplantation.World J Gastroenterol2016https://conductscience.org/library/papers/28018115PubMed
330147968Acute Hepatitis due to Garcinia Cambogia Extract, an Herbal Weight Loss Supplement.Case Rep Gastrointest Med2018https://conductscience.org/library/papers/30147968PubMed
47678183Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.Science1993https://conductscience.org/library/papers/7678183PubMed
524944404Effects of garcinia cambogia (Hydroxycitric Acid) on visceral fat accumulation: a double-blind, randomized, placebo-controlled trial.Curr Ther Res Clin Exp2003https://conductscience.org/library/papers/24944404PubMed
625732350A comprehensive scientific overview of Garcinia cambogia.Fitoterapia2015https://conductscience.org/library/papers/25732350PubMed
731772720Hepatotoxicity associated with Garcinia cambogia: A case report.World J Hepatol2019https://conductscience.org/library/papers/31772720PubMed

Download CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
41262061Hepatotoxicity of dietary supplements containing Garcinia gummi-gutta (L.) N. Robson.Pharm Biol2025https://conductscience.org/library/papers/41262061

Source PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37575813

GET https://conductscience.org/api/papers/v1/37575813/authors